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Abstract: Porphyrins are conjugated, stable chromophores
with a central core that binds a variety of metal ions and an
easily functionalized peripheral framework. By combining
the catalytic, electronic or cytotoxic properties of selected
transition metal complexes with the binding and electronic
properties of porphyrins, enhanced characteristics of the en-
semble are generated. This review article focuses on por-
phyrins bearing one or more peripheral transition metal
complexes and discusses their potential applications in catal-
ysis or biomedicine. Modulation of the electronic properties
and intramolecular communication through coordination
bond linkages in bis-porphyrin scaffolds is also presented.
1. Introduction
Natural porphyrins and their congeners, such as chlorins and
bacteriochlorins, are considered as “pigments of life” because
they are known to play significant roles in important biological
processes such as photosynthesis (role of chlorophylls in pho-
tosynthetic systems),[1] the transport and storage of molecular
oxygen (role of hematoporphyrins in blood hemoglobin and
myoglobin, respectively)[2] or catalytic oxidation reactions (role
of cytochrome P-450 enzymes).[3] Inspired by Nature, the
chemistry of tetrapyrrolic macrocyles, such as porphyrins,
phthalocyanines, porphyrazines or corroles, has rapidly grown
during the last fifty years and a large variety of porphyrin de-
rivatives are now reported in the literature. The term “metallo-
porphyrins” (and metal complexes of related phthalocyanines,
porphyrazines or corroles) usually refers to compounds where
the metal ions are coordinated within the internal cavity. The
inner metal in the porphyrin core can play various roles de-
pending on the targeted applications. It can be used as a cata-
lytic site or as a coordination site for the construction of multi-
porphyrinic systems ranging from finite dimeric species to in-
finite polymeric materials.[4]
Continuous advances in the functionalization of the b-pyrrol-
ic and meso positions of porphyrins led to the synthesis of nu-
merous porphyrinoids bearing peripheral coordination sites in
addition to the classical inner coordination site.[5] These com-
pounds offer new opportunities to anchor metal complexes at
the periphery of porphyrins. Some core-modified porphyri-
noids, such as N-confused porphyrins[6] and porphyrazines,[5]
possess nitrogen atoms in place of carbon atoms at their pe-
riphery. Although these nitrogen atoms can be used to anchor
peripheral metal complexes, these fascinating compounds are
not discussed in this review that focuses on porphyrins only.
Moreover, only porphyrins containing peripheral transition
metal complexes are presented. Therefore, porphyrins contain-
ing, for example, appended crown ethers complexing alkali
and alkaline earth metal ions are not included since they are
discussed elsewhere.[7] Here, we present selected examples of
peripherally metalated porphyrins where the outer transition
metal complexes can play key roles in catalysis, molecular elec-
tronics and biomedicine (Figure 1).
2. Catalysis with Peripherally Metalated Por-
phyrins
To explain enzymatic processes, iron porphyrins were actively
investigated as mimics of cytochrome P-450 to understand the
enzyme’s catalytic activity. Besides these iron porphyrins, differ-
ent metalloporphyrins catalyzed other reactions, including ami-
nation (with Co[8]), cyclopropanation (Rh,[9] Co,[10] Ir[11]) or olefi-
nation (Fe[12]) reactions. In this context, the use of peripherally
metalated porphyrins for catalysis is a relatively recent field of
research (less than two decades old).[13] In this case, the periph-
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Figure 1. Topics discussed in this review.
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eral transition metal complexes play the role of catalytic sites,
whereas the neighboring porphyrin can act: (i) as a modulating
unit to tune the electronic and catalytic properties of the pe-
ripheral catalytic sites, (ii) as a secondary coordination site for
supramolecular or dual catalysis, or (iii) as a light harvesting
unit for dual photoredox and transition metal catalysis. These
aspects are discussed hereafter.
2.1. Modulation of the electronic and catalytic properties
It was expected that the electronic and catalytic properties of
the peripheral metal catalyst(s) could be modulated by the
porphyrin due to possible electronic interplay between the
outer and inner metal ions. Mizoroki-Heck coupling reactions
between aryl halides and alkenes were extensively used by
several research groups as “benchmark reactions” to evaluate
the catalytic properties of porphyrins with peripheral PdII com-
plexes. In their pioneering work, Klein, Gebbink and co-workers
reported the synthesis of a series of symmetrical (metallo)por-
phyrins with four meso aryl groups bearing pincer-type ligands
with NCN, SCS or PCP donor atoms and the corresponding PdII
complexes.[14] The SCS-PdII complexes 1-M (M=MgII, NiII, MnIIICl
and 2H) were tested as pre-catalysts in the Mizoroki-Heck reac-
tion between iodobenzene and styrene (Scheme 1).[15] Catalytic
activities depended on the nature of the metal ions inside the
porphyrin, and increased in the order 1-MnIIICl<1–2H<1-
NiII<1-MgII. Complex 1-MgII was the most active catalyst with
a conversion of >95% after 5 hours. Complex 1-MnIIICl exhibit-
ed the lowest activity with a 92% conversion after 45 hours.
These catalytic activities are in line with the relative electron-
donating abilities of the porphyrins. Control experiments con-
firmed that the differences in catalytic activities arose from in-
tramolecular interactions rather than intermolecular interac-
tions. The main outcome of the study was that leached Pd par-
ticles were the possible catalytically active species. Following
this observation, it was proposed that the nature of the inner
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metal ion in the porphyrin directly influenced the electron-do-
nating ability of the porphyrin and, hence, facilitated (or not)
the leaching of Pd in the reaction mixture.
Stronger electronic interactions between the porphyrin and
peripheral metal complexes are expected in the absence of or-
thogonal meso aryl groups. For example, the meso triarylpor-
phyrin containing two pyridyl groups at the b-pyrrolic posi-
tions adjacent to the free meso carbon (see Scheme 2)[16] pro-
vides an NCN pincer-type ligand was used for the synthesis of
the corresponding PdII complexes 2-M (M=ZnII, NiII, CuII and
2H). When these complexes were used as pre-catalysts in the
Mizoroki-Heck reaction between iodobenzene and butyl acry-
late, the catalytic activity strongly depended on the nature of
the inner metal ion and increased in the order 2-2H<2-CuII<
2-NiII<2-ZnII. This observation was not discussed at that time
but it was clear that the inner metal ion had a strong impact
on the catalytic activity. Interestingly, when pyridyl ligands
were replaced by N-methyl imidazole, the apparent catalytic
activity of complex 3 in the same reaction was enhanced com-
pared to that of 2-NiII.[17] This enhancement showed that a
fine-tuning of the catalytic properties was achieved by modu-
lating the nature of the ligands at the b-pyrrolic positions
(Scheme 2). The same pincer ligand with pyridyl groups was
used for the synthesis of the IrIII complex 4, which was catalyti-
cally active towards the hydrosilylation of ethyl cinnamate
(Scheme 3).[18]
A porphyrin conjugated with a phenanthroline ligand was
used in the synthesis of PdII complexes 5-M (Scheme 4, M=
ZnII, NiII, CuII, MgII and CoII).[19] These complexes were used as
pre-catalysts for the Mizoroki-Heck reaction between iodoben-
zene and butyl acrylate. Similarly, to the results previously de-
scribed, the observed catalytic activity was found to signifi-
cantly depend on the inner metal ion. The complex 5-ZnII ap-
peared to be the most active catalyst with a 100% conversion
reached after 30 minutes. All other complexes were less active
and 5-CoII was the least active.
A ZnII meso triarylporphyrin, where the fourth meso position
was functionalized with a diphenylphosphanyl group,[20] was
used to prepare a ZnII bis(m-chloro)-bridged porphyrin append-
ed phospha-palladacycle 6-ZnII, which was further converted
to the free-base- and Ni-porphyrin analogs 6-2H and 6-NiII.
These complexes were tested as pre-catalysts in the Mizoroki–
Heck reaction between p-bromobenzaldehyde and butyl acry-
late (Scheme 5). The observed catalytic activity significantly de-
pended on the metal in the porphyrin and increased in the
order 6-2H<6-ZnII<6-NiII. However, this order does not coin-
cide with the electron-donating ability of the porphyrin p-
system, estimated from the first oxidation potentials. However,
Scheme 1. Mizoroki-Heck reaction catalyzed by Pd complexes 1-M.
Scheme 2. Mizoroki-Heck reaction catalyzed by Pd complexes 2-M and 3.
Scheme 3. Hydrosilylation reaction catalyzed by Ir complex 4.
Scheme 4. Mizoroki-Heck reaction catalyzed by Pd complexes 5-M.
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this order did correlate with the s-donating ability of the phos-
phorus atom (estimated by 31P NMR spectroscopy), which in-
creases in the order: 6-NiII<6-2H<6-ZnII. Comparisons with
the previously described Mizoroki–Heck reactions are difficult
because aryl halides and catalyst loadings were different.
Since palladacycles readily decompose during Mizoroki–
Heck reactions (see the previous examples), other types of pe-
ripheral ligands were studied. N-heterocyclic carbenes (NHCs)
are known to form very stable bonds with transition metal
ions in low and high oxidation states and thus are actively
used in organometallic chemistry and catalysis. Porphyrins
fused to imidazolium salts 7-M[21] serve as NHC precursors for
the synthesis of bis(m-iodo)-bridged PdII complexes 8-M (M=
NiII, CuII, ZnII and 2H).[22] These complexes were tested as pre-
catalysts in the Mizoroki–Heck reaction between iodobenzene
and styrene (Scheme 6) and the observed catalytic activity de-
pended on the absence or presence of a metal ion in the por-
phyrin. A conversion between 80–90% of iodobenzene was
observed with compounds 8-M (M=NiII, CuII and ZnII), whereas
only 30% was observed with the free-base porphyrin 8-2H
after 10 hours. Pd leaching occurred during the reaction and it
was shown that leached Pd could be trapped by the inner co-
ordination site of the porphyrin, thus decreasing the concen-
tration of free Pd particles available for the coupling reaction.
Interestingly, in almost all Mizoroki–Heck reactions presented
so far in this section, the pre-catalysts incorporating free-base
porphyrins are among the least active ones. Of course, steric
and electronic properties are important, but other factors (axial
coordination, solubility, etc.) should also be taken into account,
including the possible trapping of Pd in the porphyrin macro-
cycle.
Many experimental observations made in the course of
these investigations suggest that PdII complexes decompose
and release Pd0 colloids at elevated temperature, including
when NHC-PdII complexes are used as pre-catalysts.[23] The Miz-
oroki–Heck reaction was probably not the best choice to dem-
onstrate the electronic interplay between the inner metal in
the porphyrin and the peripheral catalytic site. Therefore, other
reactions and catalysts were investigated. In the course of their
studies, Richeter and co-workers synthesized the RhI com-
plexes 9-M (M=NiII, ZnII, MnIIICl, AlIIICl, 2H and 4H2+ , see
Scheme 7).[24] The electron donating abilities of the peripheral
NHCs were evaluated from the stretching vibrations of the CO
ligand on RhI complexes 9-M. The s-donating ability of the
NHCs increased in the order M=4H2+<AlIIClMnIIICl<NiII
2HZnII.[24,25] IR spectroscopy was not sensitive enough to
distinguish between 9-ZnII, 9-NiII and 9-2H. However, the very
small differences observed are in good agreement with the p-
donating ability of the porphyrins, estimated from the first oxi-
dation potentials of imidazolium salts 7-M. These potentials
are shifted anodically in the order 7-ZnII (+0.36 V)<7-2H (+
0.57 V)<7-NiII (+0.64 V). Imidazolium salts 7-M (M=NiII, ZnII,
MnIIICl, 2H; see Scheme 6) were used as NHC precursors to cat-
alyze the ring-opening polymerization (ROP) of l-lactide (l-LA)
(Scheme 8).[24] The observed catalytic activity strongly depend-
ed on the metal ion inside the porphyrin and increased in the
order 7-MnIIICl<7-NiII<7-2H<7-ZnII. This order coincides
with the s-donating ability of the NHCs as well as the p-donat-
ing ability of the porphyrins; the more electron-rich the por-
phyrin, the more catalytically active the peripheral NHC is to-
wards the ROP of l-LA.
A phosphorus-containing PCP pincer-type ligand and the
corresponding PdII 10-M and PtII 11-M complexes (M=NiII, ZnII
and 2H)[26] were tested in the allylation reaction of benzalde-
hyde with allyltributyltin, because this reaction is known to
proceed without significant decomposition of the catalyst
(Scheme 9). However, the obtained data showed similar cata-
Scheme 5. Mizoroki-Heck reaction catalyzed by Pd complexes 6-M.
Scheme 6. Mizoroki-Heck reaction catalyzed by Pd complexes 8-M.
Scheme 7. Structures of RhI complexes 9-M. and n(CO) values measured by
IR spectroscopy.
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lytic activity for all catalysts, implying that the inner metal had
little or no influence on the peripheral catalytic sites. The PdII
complexes 10-M (M=ZnII, NiII and 2H) were also tested for the
1,4-reduction of chalcone through transfer hydrogenation
(Scheme 9). In this case, the catalytic activity depended on the
nature on the inner metal and increased in the order 10-2H
10-NiII<10-ZnII. The higher activity observed for 10-ZnII is in
agreement with its lower oxidation potentials compared to
those of 10-NiII and 10-2H, that is, the ZnII porphyrin is more
electron-rich than the other two. It is important to note here
that mercury poisoning tests excluded the formation of Pd
nanoparticles in the course of the reaction.
2.2. Dual catalytic systems and supramolecular assemblies
As seen above, the modulation of the electronic properties of
the aromatic core by the nature of the metal ion inside the
porphyrin can have significant impact on the electronic and/or
catalytic properties of peripheral metal complexes. However,
the central metal ion can also be used as a secondary catalytic
site for dual catalysis. Cationic PdII complexes 12-M (M=MgII,
NiII, ZnII and 2H; Scheme 10) constructed from por-
phyrins bearing an NCN pincer-type ligand were
tested as catalysts in the double Michael addition of
ethyl-a-cyanoacetate with methyl vinyl ketone.[27]
The observed catalytic activity did not depend of
the porphyrin when M=ZnII, NiII or 2H and was simi-
lar to the activity of the corresponding non-porphy-
rin complex. Interestingly, the catalytic activity in-
creased by a factor of six when M=MgII. Control ex-
periments suggest that simultaneous activation of
methyl vinyl ketone by coordination of the carbonyl
group to the Lewis acidic MgII site and activation of
ethyl-a-cyanoacetate bound to the cationic PdII com-
plex within supramolecular assemblies may explain
the enhanced activity. Interestingly, combining
MgIITTP and cationic [Pd(NCN)OH2]BF4 into one mol-
ecule 12-MgII led to a three-fold increase of its catalytic activity
compared to that found for a 1:1 mixture of its constituents.
Indeed, the MgII porphyrin and the peripheral PdII complex act
in a cooperative way when they are connected together.
Other reported examples of such “cooperative dual catalytic
systems” include the synthesis of phenanthroline-strapped por-
phyrin [2]rotaxanes by a copper-catalyzed alkyne-azide cyclo-
addition.[28] The cooperative and simultaneous activation of
both the azide, by the ZnII porphyrin of 13, and of the alkyne,
by the phenanthroline-bound CuI, dramatically improved the
yield of rotaxanes (Scheme 11).
Metalloporphyrins are also attractive molecules in the field
of supramolecular chemistry. Well-defined finite species can be
obtained by self-assembly via axial coordination to metal ions
such as ZnII in the porphyrins. In catalysis, this supramolecular
Scheme 8. Polymerization of l-LA catalyzed by porphyrin-NHCs generated in situ by de-
protonating imidazolium salts 7-M. Plots of ln([l-LA]0/[l-LA]t) versus time for [l-LA]0=2m
and a targeted degree of polymerization of 100.
Scheme 9. Allylation reaction of benzaldehyde with allyltributyltin and 1,4-
reduction of chalcone through transfer hydrogenation catalyzed by PdII
complexes 10-M and PtII complexes 11-M.
Scheme 10. Double Michael addition of ethyl-a-cyanoacetate with methyl
vinyl ketone catalyzed by complexes 12-M. Below: possible mechanism to
explain the increased catalytic activity when M=MgII.
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approach was applied to construct bidendate ligands by com-
bining two phosphorus-based ligands, one with a pyridyl
ligand as donor and another appended to a ZnII porphyrin
(Scheme 12).[29] The self-assembled Supraphos ligand 14 was
successfully used for the challenging Rh-catalyzed, hydrogena-
tion of enamide substrates, the Pd-catalyzed kinetic resolution
of racemic cyclohexenyl acetate, and the Rh-catalyzed hydro-
formylation of styrene. The powerful aspect of this supra-
molecular approach is that a vast library of 48 bidendate li-
gands was obtained from only six porphyrin derivatives and
eight monodentate phosphorus ligands.
2.3. Photocatalysis
Generally, Ru and Ir complexes are at the forefront of photore-
dox catalysis because of their high redox potentials in the ex-
cited states.[30] Visible light is used to perform photoinduced
electron transfer with substrates through oxidative/reductive
quenching pathways. Combining a photosensitizer with a
second metal catalyst leads to dual catalytic systems with
novel reactivity that is sometimes not accessible using either
of the compounds independently.[31] Most of the time, the two
components are not linked together (bimolecular systems).
Dual catalytic systems where the two components are con-
nected, that is, in close proximity (unimolecular systems), and
able to act in a cooperative way are less common. Some chal-
lenging reactions could surprisingly be achieved or enhanced
with such systems under visible light irradiation (“photo-assist-
ed” catalysis). Porphyrin derivatives, which have redox poten-
tials in their excited states and their ground states close to
those of [Ru(bpy)3]
2+ ,[32] can be used for photocatalytic applica-
tions such as reduction of CO2 to CO or H2 evolution.
Converting CO2 into valuable chemicals is of interest espe-
cially if solar energy is employed. Towards this goal, a series of
ReI complexes 15-M (M=CuII, PdII, ZnII, CoII and FeIIICl) based
on a porphyrin conjugated with a phenanthroline ligand.[33]
were tested as catalysts for the photochemical reduction of
CO2 to CO in DMF using triethylamine as a sacrificial electron
donor (Scheme 13). For these heterodinuclear complexes, the
active catalytic center is the peripheral ReI complex and not
the (metallo)porphyrin. The nature of the metal center in the
porphyrin, as well as the irradiation conditions, strongly influ-
ences the reduction of CO2 to CO. The Re
I complex conjugated
with the ZnII porphyrin 15-Zn is the most active photocatalyst
with a turnover number (TONCO) of 13 after 24 hours of irradia-
tion at l>375 nm. All other photocatalysts show minimal ac-
tivity under these conditions. Investigation of the
photoreduction of CO2 by three types of Zn
II porphy-
rin-ReI dyads 16, 17 and 18 showed that the TONCO
obtained with 18 was 360 after 7 hours of irradiation
at l>520 nm (Scheme 13).[34] This value is one order
of magnitude higher than those of 16 and 17. It was
also noticed that the ZnII porphyrins were reduced
to ZnII chlorins (and ZnII isobacteriochlorins), which
are also active sensitizers. Complete bleaching ren-
ders the dyads inactive. Interestingly, the use of a sa-
turated bridge between the porphyrin and the ReI
complexes was beneficial and in accord with results
obtained for RuRe complexes.[35]
Scheme 11. Synthesis of phenanthroline-strapped porphyrin [2]rotaxane 13
through a Cu-catalyzed alkyne-azide cycloaddition reaction.
Scheme 12. Schematic representation of a RhI complex with Supraphos ligand 14 for the
Rh-catalyzed hydroformylation of styrene.
Scheme 13. Structures of porphyrin ReI complexes 15-M, 16, 17 and 18 for
the photoreduction of CO2 to CO.
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Photochemical production of H2 with noble-metal-free mo-
lecular species is still a hot topic for the development of future
cost-effective, environmentally benign sources of energy. Com-
plexes belonging to the class of cobaloximes are active cata-
lysts for the photoinduced generation of H2. Sun and co-work-
ers reported the synthesis of porphyrins 19-M (M=ZnII, MgII
and 2H) with one meso 4-pyridyl group that acts as an apical
ligand for the complex [CoIII(dmgH)2(Cl)]
0 (dmg=dimethyl-
glyoxime, Scheme 14).[36] Photoinduced (l>400 nm) H2 gener-
ation, in a THF–H2O solution containing NEt3, with 19-M as
photocatalysts, strongly depends on the inner metal of the
porphyrin. A TONH2 of 22 was observed after 5 hours with 19-
ZnII, whereas only a value of 3 was reached for 19-MgII after
3 hours. Only trace amounts of H2 were detected for 19-2H
under these conditions. Guldi, Coutsolelos, Gryko and co-work-
ers investigated photophysical and catalytic properties of simi-
lar dyads 20-M (M=Zn and 2H) and discussed the possible
photochemical processes leading to the formation of catalyti-
cally active species (Scheme 14).[37] Again, the photocatalyst
20-ZnII was the most efficient for H2 evolution. In other photo-
catalytic studies with PtII complexes 21-M and 22-M[38] based
on a porphyrin conjugated with a phenanthroline ligand, the
catalytic evolution of H2 depended on the nature of M in the
inner core of the porphyrin and the halides bound to the PtII
center. The optimal photocatalyst was 21-ZnII with X=Cl
(TON48h=25 and 2, respectively for 21-Zn
II and 22-ZnII ; l=
470 nm in CH3CN/trimethylamine/H2O 6:3:1).
3. Molecular Electronics with Porphyrins As-
sembled by Transition Metal Ions
Mimicking the properties of natural systems with synthetic
porphyrin derivatives has been the subject of intense research
during the last few decades. Porphyrin dimers and oligomers
assembled by covalent or non-covalent bonds have been in-
vestigated to better understand the electronic interactions be-
tween the chromophores in their ground and excited states. In
this section, some representative examples of porphyrin
dimers and oligomers assembled by transition metal ions are
presented along with the factors important for efficient elec-
tronic communication between the porphyrins.
3.1. Factors governing electronic interactions between por-
phyrins in the ground state
An early example of a porphyrin dimer assembled by a transi-
tion metal was reported by Lehn and Drain (Scheme 15).[39] In
dimer 23, meso 4-pyridyl units are used as peripheral ligands
and square-planar PdII ions with a trans geometry are used as
assembling metals. The electronic interactions between the
porphyrins through the assembling metal were evaluated in
the ground state by UV-visible spectroscopy. Soret absorption
bands of such porphyrin dimers are moderately red-shifted (6–
8 nm) and extinction coefficients per porphyrin (80%) are
substantially lower than that of the parent porphyrin. These
observations suggest that electronic communication between
the porphyrins is quite weak. The lack of interactions between
the porphyrins of dimer 23 can be attributed to the fact that
the meso pyridyl ligands are nearly orthogonal to the porphy-
rin planes. Although porphyrin-porphyrin interactions are
weak, this is an extremely powerful approach to build complex
multiporphyrinic architectures.[40] Porphyrin dimer 24 and other
oligomers with similar pyridyl bridging units (Scheme 15)[41]
contain a platinum ion directly linked to the porphyrin core.
Despite the direct s-bond between one porphyrin and the PtII
complex, only weak electronic interactions were observed be-
tween the porphyrins (Soret bands are red-shifted by 1–
5 nm when inner M=NiII). As stated by the authors, the bridg-
ing metal fragment “acts more as a structural component than
a conjugative linking group” in this case.
With this in mind, porphyrins with coplanar and conjugated
peripheral coordination sites were expected to display larger
electronic interactions between the porphyrins within dimeric
structures. However, this is not always the case, as seen for
trans-[PdIII2(NHC)2] complexes 25-M in which two porphyrin-
NHC ligands are coordinated to PdII (Scheme 16).[42] Clearly, the
UV-visible spectra of the dimeric structures 25-M correspond
to the sum of the spectra of the individual porphyrins, and the
Scheme 14. Structures of porphyrin cobaloxime complexes 19-M and 20-M,
and PtII complexes 21-M and 22-M for photoinduced H2 generation.
Scheme 15. Structures of dimeric species 23 and 24.
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cyclic voltammograms (CVs) of complexes 25-M are similar to
the sum of the CVs of the individual porphyrins. These data
suggest that there is no electronic communication between
the porphyrins despite the conjugation between the porphyrin
core and the NHC ligands. DFT calculations corroborated the
experimental findings: no significant atomic contribution of
the coordination unit (PdII and carbene) was found in the fron-
tier orbitals, thus preventing orbital overlap between the por-
phyrins through the assembling metal.[43]
In previous systems 23–25 porphyrin cores, peripheral li-
gands and/or assembling metal (PdII or PtII) are not coplanar.
The planarity of the entire assembly can be enforced by intro-
ducing peripheral chelating sites conjugated with the porphy-
rin p-system. Porphyrins conjugated with an enaminoke-
tone 26-M were used to construct fully planar dimeric species
where the porphyrins are assembled by square-planar metal
ions such as PdII or PtII (Scheme 17).[44] In these dimers, 27-M
and 28-M, strong electronic interactions were observed in the
ground state between the porphyrins.[45]
The UV-visible spectra of the dimers 27-M do not corre-
spond to the sum of the UV-visible spectra of the individual
porphyrins 26-M. The intense Soret absorption bands are
broad and split and the Q absorption bands (500–700 nm) are
bathochromically shifted with respect to the monomeric por-
phyrins (See Figure 2a for UV-visible absorption spectra of mo-
nomer 26-Ni and dimer 27-Ni). The electronic communication
between the porphyrins through the assembling metal was
confirmed by electrochemical studies. For monomeric porphyr-
ins 26-M, two monoelectronic reversible oxidation and two
monoelectronic reversible reduction processes were observed
by cyclic voltamperometry. The cyclic voltammograms of the
dimeric species 27-M did not correspond to the sum of the
electrochemical properties of individual porphyrins
and some significant changes were observed. First,
electrochemical gaps (DE=Eox1Ered1) decreased
when going from monomers 26-M to dimers 27-M.
Second, some redox potentials are split, notably the
first oxidation waves, which are split into two well-
defined one-electron processes with splitting values
(DE=Eox2Eox1) ranging from 120–180 mV for
dimers 27-M (splitting value is 160 mV for 27-Ni, see
Figure 2b). This phenomenon is also observed in
conjugated dimeric species where porphyrins are
linked together by covalent organic spacers (80 mV
and 260 mV for a C=C and CC, respectively).[46, 47]
The highest splitting value reported so far is 410 mV
Scheme 16. Structures of PdII complexes 25-M and representation of the
HOMO orbital of the 25-Zn complex calculated by DFT.
Scheme 17. Structure of porphyrins conjugated with enamino(thio)ketone 26-M and 29-
M and dimeric species with PdII (27-M and 30-M), and PtII (28-M and 31-M) as assem-
bling metal ions.
Figure 2. a) UV–visible absorption spectra of 26-Ni and 27-Ni. b) Cyclic vol-
tammograms of 26-Ni and 27-Ni. c) Representation of the HOMO of PdII
complex 27-2H calculated by DFT.
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for Cb-Cmeso-Cb triply fused Ni
II porphyrin dimers reported by
Osuka and co-workers.[48] The splitting of the first oxidation
wave is due to the delocalization of the resulting radical cation
over both porphyrins. This delocalization renders the oxidation
of the second porphyrin more difficult. DFT calculations
showed a significant atomic contribution of the d orbitals of
the linking metal to the frontier molecular orbitals, allowing
electronic communication between the two porphyrins (Fig-
ure 2c).
Interestingly, replacement of the oxygen atom of the chelat-
ing site by a sulfur atom was feasible with Lawesson’s reagent
(see structure of 29-M).[49,50] This small change led to enhanced
electronic interactions between the porphyrins in the
dimers 30-M (splitting value is 190 mV for 30-Ni). Replacement
of PdII by PtII also dramatically enhanced the electronic com-
munication between the porphyrins in dimers 28-M and 31-M
as demonstrated by splitting values of the first oxidation
waves of 220 and 280–290 mV for 28-Ni and 31-Ni, respective-
ly. Higher oligomers, such as trimers 32 and 33 linked by coor-
dination bonds (Scheme 18) were constructed from porphyrins
bearing two peripheral chelating sites.[51] Again, electronic in-
teractions between the individual porphyrins were observed.[52]
Meso triarylporphyrins in which the fourth meso position
was unsubstituted and one of the two neighboring b-pyrrolic
positions was functionalized with a pyridyl group were used as
building blocks for the synthesis of a cofacial dimer 34 with a
Cmeso-Pt
II-Cmeso linkage in a cis geometry (Scheme 19).
[53] The
two porphyrins strongly interact through the cis PtII, as shown
by electrochemical studies. A splitting value of 230 mV be-
tween the first two one-electron oxidation waves was ob-
served. Interestingly, this dimer shows helical chirality, which
may be useful for asymmetric catalysis. In contract to 34, the
electronic communication is quite weak in coplanar Cb-to-Cb
PdII and PtII porphyrin dimers 35 and 36 with a trans geometry
(Scheme 19).[54] A meso diphenylphosphanyl group was used
to construct these coplanar dimers with Cb-M-Cb linkages (M=
PdII or PtII). Electrochemical studies revealed small splitting
values, ranging from 40 mV (PdII in 35) to 60 mV (PtII in 36), be-
tween the first two one-electron oxidation waves. A similar
splitting value of 60 mV was reported for a series of butadiyne-
and PtII diacetylide-bridged conjugated porphyrin dimers.[55]
In Cmeso-to-Cmeso Pt
II-bridged porphyrin dimers 37 and 38 with
trans and cis geometry, respectively (Scheme 20),[56] strong
electronic communication between the two porphyrins was
demonstrated by UV-visible spectroscopy and electrochemical
Scheme 18. Structures of trimers 32 and 33.
Scheme 19. Structures of dimeric species 34–36.
Scheme 20. Structures of trans-dimer 37 and cis-dimer 38. Structure of the
meso–meso linked dimer 39 obtained after chemical or electrochemical oxi-
dation of the cis-dimer 38.
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studies. For the trans-dimer 37, the splitting value of
the first oxidation wave was 170 mV, which is in the
range of values found for dimers 27-M. DFT calcula-
tions showed a clear contribution of the PtII d orbi-
tals in the trans geometry to the frontier molecular
orbitals. A through-bond conjugation between the
porphyrins was postulated. For the cis-dimer 38, DFT
calculations showed through-space interactions be-
tween the porphyrins in the frontier molecular orbi-
tals, notably between the two carbon atoms linked
to PtII. Interestingly, the electrochemical behavior of
the cis-dimer 38 was very different because a chemi-
cal transformation occurred after the first oxidation,
leading to the formation of the meso-meso linked
dimer 39 through a surprising reductive elimination.
This transformation could also be achieved by a
chemical oxidation.
3.2. Electronic interactions between the porphyr-
ins in the excited state
Natural porphyrin analogues such as chlorophylls
and bacteriochlorophylls ensure energy and electron
transfer processes in photosynthetic systems with
high efficiencies and rates (as fast as 100–150 femto-
seconds for some energy transfers).[57] Several donor-
acceptor (D-A) systems with different geometries,
orientations and distances between the chromo-
phores were studied in order to better understand
energy and/or electron transfer processes. However,
transition-metal complexes as bridging units in D-A
assemblies are less studied than covalently linked systems. Pio-
neering works by several authors including J.-P. Sauvage and
co-workers studied electron transfers in bis-porphyrinic D-A
systems like 40, where the individual units were connected by
metal ions (Scheme 21).[58] Later, other systems were built to
study the faster energy transfer processes (see dyads 41–43 in
Scheme 21).[43,59,60] In this section are summarized some impor-
tant results concerning S1 energy transfer rates within molecu-
lar D-A systems, where D and A are assembled with metal
complexes.
There are two possible processes of S1 energy transfer be-
tween D and A within dyads, namely Fçrster and Dexter mech-
anisms (Figure 3). The Fçrster resonance energy transfer (FRET)
mechanism is a “through space” coulombic energy transfer
that necessitates a close proximity (1–10 nm) between D
and A (Figure 3a). The Dexter mechanism is a “through bond”
exchange energy transfer occurring only over short distances
(<1 nm) between D and A. As this mechanism corresponds to
a double exchange of electrons between D and A, molecular
orbital overlap between them is essential (Figure 3b). As
shown in the next paragraphs, the S1 energy transfer rates be-
tween D and A within molecular D-A systems vary dramatically
by modifying the nature of the peripheral ligands and the
bridging transition metal ions.
Photophysical studies of the dyad 41, where a PdII porphyrin
(D) and a ZnII porphyrin (A) are linked together by an organo-
metallic spacer (Scheme 21),[59] showed that the energy transfer
rates were quite slow (S1 energy transfer rate of 500 ps).
Energy transfer rates were also slow (S1 energy transfer of
90–330 ps) in dyad 42 containing a ZnII porphyrin (D) and a
free-base porphyrin (A) fused to peripheral NHC ligands and
Scheme 21. Structures of dyads 40–43 with donors in blue and acceptors in pink.
Figure 3. Schematic diagrams of Fçrster (a) and Dexter (b) energy transfer
processes between a donor (D) and an acceptor (A).
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linked together by a trans PdIII2 complex.
[43] DFT calculations for
42 clearly showed the lack of PdII atomic contributions to the
p-system of the frontier molecular orbitals (Figure 4, left side).
Therefore, the Dexter mechanism cannot operate and S1
energy transfer is only due to Fçrster resonance energy trans-
fer (FRET). However, the S1 energy transfer rate is much slower
than the predicted values when considering only FRET. This
slow transfer may be explained by an electric field screening of
the donor and the acceptor transition moments by the elec-
tron-rich trans PdIII2 complex, which slows down the energy
transfer rate.
Energy transfer rates in the two previous dyads 41 and 42
suggest that the presence of a transition metal in the bridge
between the porphyrins has a negative impact on the energy
transfer rates between the porphyrins, but this is not always
the case. For example, a ZnII porphyrin (D) and a free-base por-
phyrin (A), each bearing an enaminoketone, were assembled
around a square planar PdII to give dyad 43 that exhibited a
very fast S1 energy transfer that takes place in 660 fs.[60] This
value is comparable to the one found for covalently meso–
meso linked bis-porphyrins (550 fs).[61] This fast rate is due to
a strong electronic communication between the porphyrin
through the assembling PdII. DFT calculations show a signifi-
cant atomic contribution of the d orbital to the frontier molec-
ular orbitals (MO) (4.6% for the HOMO) allowing orbital over-
lap between the two porphyrins. Consequently, the Dexter
mechanism operates efficiently (Figure 4, right side). Moreover,
the absence of additional ligands on the square planar PdII is
probably beneficial since there is no electric field screening
effect of ancillary ligands. Replacing PdII by PtII significantly de-
creases the time needed for the S1 energy transfer, which is
105 fs for the dyad 44 because PtII allows stronger molecular
orbitals coupling between the two porphyrins (Scheme 22).[62]
DFT calculations showed higher atomic contribution of the PtII
d orbital to the frontier MO compared to PdII (11.2% for the
HOMO). The fastest S1 energy transfer (<50 fs) was reached in
dyad 45 where oxygen atoms were replaced by sulfur atoms in
the peripheral chelating sites.[50] Again, DFT calculations
showed higher atomic contribution of the PtII d orbital to the
frontier MO (13.5% for the HOMO) leading to increased molec-
ular orbitals coupling between the porphyrins and better elec-
tronic communication.
In conclusion, the use of transition metal ions as linkers be-
tween a donor and an acceptor is feasible and dyads with ul-
trafast energy transfer rates can be obtained by judiciously
choosing the ligands and the metal ion. One disadvantage of
these systems compared to covalently linked dyads is that the
heavy atom effect of the bridging metal favors the formation
of the T1 state by depleting the S1 state (intersystem crossing,
ISC). Nevertheless, this ISC is of great importance when consid-
ering other applications, such as photodynamic therapy, dis-
cussed in the next section.
4. Photodynamic Therapy Applications
In the field of biomedical applications, porphyrin derivatives
are mainly used as photosensitizers (PS) for photodynamic
therapy (PDT) applications. For effective PDT, light and molecu-
lar oxygen (3O2) are the two essential elements in addition to a
PS. Ideally, the PS is first accumulated in cancer cells and then
irradiated with light. As shown in the simplified Jablonski dia-
gram in Figure 5, the PS absorbs light at a suitable wavelength
(ideally in the photo-therapeutic window 650–900 nm for
better depth penetration through tissues) to promote the S0!
S1 excited state. Then, the singlet excited state S1 is converted
to the lower energy excited triplet state T1 through ISC. The PS
in its T1 state can transfer its energy to
3O2 to generate reactive
singlet oxygen (1O2), which is a highly oxidizing and cytotoxic
agent. PDT offers spatial and temporal control because the
generated 1O2 has lifetimes of 3 ms and limited diffusion co-
efficients of 2–4106 cm2 s1 in biological media.[63,64] In this
section, representative examples of porphyrin-based PS periph-
Figure 4. Representation of the frontier molecular orbitals HOMO and LUMO
for dyads 42 and 43.
Scheme 22. S1 energy transfer in dyads 43–45.
Figure 5. Simplified Jablonski diagram explaining the photophysical process-
es leading to the formation of 1O2.
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erally metalated with transition metal ions are presented. The
benefits obtained from these metal complexes for therapy and
imaging applications will be emphasized.
4.1. Porphyrins with peripheral platinum complexes
Platinum complexes are powerful anticancer agents and one
identified mode of action is their ability to crosslink purine
bases of DNA. These stable complexes interfere with DNA
repair machinery and ultimately lead to death of cancer cells.
Cisplatin and carboplatin are active towards bladder, ovarian,
head, neck, testicular and lung cancers. However, many side ef-
fects are associated with the use of these complexes. To im-
prove their efficiency and limit the side effects, Pt complexes
are combined with molecules known to preferentially accumu-
late in tumor tissues. Song and co-workers synthesized free-
base porphyrins 46 with three meso 4-methylpyridinium
groups that ensure water solubility (Scheme 23).[65] The fourth
meso position was functionalized with an aryl group bearing
PtII complexes. The anticancer properties of such PtII porphyrin
conjugates are superior to those of cisplatin due to a higher
accumulation in tumors because of the porphyrin.
Porphyrin derivatives with peripheral PtII complexes can be
used for dual chemo- and phototherapy because they com-
bine within the same molecular species the antitumor activity
of PtII complexes and the phototoxicity of porphyrins upon ir-
radiation with light. Brunner and co-workers investigated in
detail the use of hematoporphyrin derivatives 47 as PS for PDT
with cis PtII complexes coordinated to the two carboxylate
groups of the propionate side chains (Scheme 23).[66] The most
active compounds are those with two amine ligands bound to
PtII, and with polyethyleneglycol units (PEG) for solubility in
water. The same group synthesized free-base porphyrins with
three meso aryl groups bearing PEG chains, while the fourth
meso aryl group was functionalized with PtII complexes.[67] A
representative example is the PtII porphyrin conjugate 48 in
Scheme 23.[67a] As for PtII hematoporphyrin conjugates, the
free-base porphyrin improved the anticancer activity of the PtII
moiety by an additional photodynamic effect upon irradiation
with red light. The light-induced toxicity is improved compared
to their hematoporphyrin analogues when irradiated under the
same conditions (l=600–730 nm; 10 min; 24 Jcm2).
Tetraplatinated porphyrins 49 and 50 (Scheme 24), obtained
by reacting the free-base meso-tetra(4-pyridyl)porphyrin with
PtII complexes, were used for photodynamic therapy applica-
tions.[68] The 1O2 quantum yields (FD) of 49 (cis geometry) and
50 (trans geometry) are higher than that of the corresponding
non-platinated porphyrin, suggesting that the PtII ions pro-
mote the formation of the T1 state through a heavy atom
effect. In vitro studies were performed on different cell lines.
Interestingly, PtII-porphyrin conjugates 49 and 50 show very
limited toxicity on HeLa cells in the dark compared to cisplatin,
but the toxicity upon irradiation (incubation time: 4 hours, irra-
diation conditions: l=420 nm, 15 mn, 6.95 Jcm2) is 600–
1200 times higher. The factor corresponding to the phototoxic
index (PI= IC50 in the dark/ IC50 irradiated) for PS 50 is >5000
in cisplatin-resistant cell line CP70 suggesting that dual
chemo- and phototherapy is a very promising approach for
cancer therapy. Subcellular colocalization studies showed im-
proved accumulation of these PS in the nucleus (30 times
more than cisplatin). This is a great advantage because DNA is
the main identified biological target for PtII complexes. Viscom-
etry experiments, emission and absorption spectroscopy, circu-
lar dichroism studies and NMR spectroscopy showed that PS
50 can interact with DNA; although no damage of DNA was
observed in the dark, significant cleavage and damage of the
DNA occurred upon light irradiation.
The use of meso-3-pyridyl ligands instead of meso-4-pyridyl
ligands has a significant impact on the PDT efficiency
(Scheme 24).[69] Both tetraplatinated porphyrins 51 and 52
have high singlet oxygen quantum yields, and are phototoxic
at the nanomolar scale. However, PS 52 (3-pyridyl) is twice as
phototoxic as 51 (4-pyridyl) despite a lower FD. The overall
better efficiency of PS 52 was attributed to its higher intracel-
lular concentration compared to PS 51. The different charge
distribution in 51 and 52 confers more amphiphilicity to 52
Scheme 23. Structures of PtII-porphyrin conjugates 46–48.
Scheme 24. Structures of H2TPyP and Pt
II-porphyrin conjugates 49–52. 1O2
quantum yields FD indicated determined in DMF for H2TPyP, 49 and 50 and
in CH3CN for 51 and 52.
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and thus better membrane affinity or permeability and cellular
uptake. Therefore, the PS with the highest FD is not always
the best PS for PDT. The number, the nature and the localiza-
tion of the peripheral metal complexes are important factors
to consider when designing a PS for dual chemo- and photo-
therapy. The observed benefits of these PtII complexes are due
to synergistic effects (the overall effect is greater than the sum
of individual effects): the porphyrin macrocycle improves the
cellular uptake of PtII complexes possibly via low density lipo-
proteins (LDL) receptors over-expressed by cancer cells, where-
as the PtII complexes enhanced the water solubility and the
photodynamic properties of the porphyrin through a heavy
atom effect.
Interaction of PtII porphyrin conjugates with DNA is property
necessary for dual chemo- and photo-therapy. Particularly in-
teresting DNA sequences include G-rich DNA sequences of the
telomeres at the end of chromosomes. These sequences are
able to form G-quadruplexes (G4, see Figure 6) by p–p stack-
ing of G-quartets, which are formed by four guanines
assembled through complementary hydrogen bonds.
These G4 structures seem to play an important role
in cell aging processes. Flat cationic molecules such
as H2TMPyP (Scheme 24) can stabilize G4 structures
and display anticancer properties by inhibiting the
activity of telomerase, an enzyme responsible for
maintaining the integrity of the telomeres. Mao et al.
showed that the methyl group of the pyridinium
units of H2TMPyP could be replaced by cationic Pt
II
complexes in clover-like compounds 53 and 54
(Scheme 25).[70] Both compounds display high affinity
for G4 structures and, more importantly, a higher se-
lectivity for G4 rather than for double stranded DNA
with an end-stacking binding mode (Figure 6). They
display anticancer activities on HeLa cells by inhibit-
ing the telomerase activity and also by repressing
oncogene expression. The photodynamic properties
of these compounds have not yet been investigated.
4.2. Porphyrins with peripheral ruthenium complexes
Ruthenium-based compounds appear to be an attractive class
of metallodrugs able to interact with DNA and proteins be-
cause they are usually less toxic than their PtII counterparts.
Moreover, ruthenium polypyridyl complexes can generate reac-
tive oxygen species upon irradiation, leading to DNA damage.
As with PtII complexes, the combination of ruthenium com-
plexes with porphyrins was investigated for dual chemo- and
photo-dynamic therapy. In an early example, four RuI com-
plexes were anchored to a free-base meso-tetrakis(4-pyridyl)-
porphyrin (55 : Scheme 26), which was able to photoinduce ox-
idative cleavage and modification of DNA.[71]
The anticancer and photodynamic properties of porphyr-
ins 56-X and 57-X functionalized with arene RuII complexes
were investigated as potential photosensitizing chemothera-
peutic agents (Scheme 26).[72] These complexes accumulated in
Me300 melanoma cells cytoplasm and were moderately toxic
in the dark (IC5010 mm for 56-A and 20 mm for 56-B, 57-A
and 57-B, after 72 h incubation). Complexes 56-A and 57-A
were proven to shut down DNA synthesis by inhibiting incor-
poration of thymidine. Therefore, protein synthesis and cell
Figure 6. Structures of a G-quartet and a G-quadruplex. Illustration of the
end-stacking binding mode of 53 or 54 with a G-quadruplex.
Scheme 25. Structures of H2TMPyP and Pt
II-porphyrin conjugates 53 and 54.
Scheme 26. Structures of RuII-porphyrin conjugates 55–58.
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survival were diminished. Upon irradiation with red
light (l=652 nm), excellent phototoxicities were ob-
served. Photodynamic studies revealed that RuII
complexes with 3-pyridyl ligands were more efficient
than those with 4-pyridyl ligands. Interestingly, the
same observation was made with PtII complexes 51
and 52, suggesting that attaching the metal com-
plexes in the meta positions of the meso aryl groups
was the best choice. The potential of cationic octa-
nuclear RuII-porphyrin metalla-cubes 58-X for
chemo- and phototherapy was also studied.[73] Both
compounds displayed excellent cytotoxicity towards
melanoma cells Me300 (IC50 5 and 9 mm for 58-A
and 58-B, respectively) and were more toxic than
the corresponding tetra-RuII complexes 56-A and 56-
B. The metalla-cubes 58-X were not toxic towards
pulmonary (A549) and cervical (HeLa) cancer cells
(IC50>70 mm), but exhibited good phototoxicity
upon irradiation at 652 nm (75% cell death at
1 mm concentration and a light dose of 10 Jcm2).
A current focus point in the field of PDT is the use
of two-photo absorption (TPA) to generate 1O2. This
technique consists in the simultaneous interaction of
a PS with two photons of low energy. TPA can be
performed with lasers at wavelengths higher than
800 nm, which allow deeper penetration of the light
through tissues. Moreover, spatial resolution of the treatment
is excellent because TPA occurs at the diffraction-limited beam
focus, resulting in minimal side damage along the beam path.
Monomeric porphyrins have relatively low TPA cross-sections
(s2<30 GM) and are not suitable PS for TPA. To increase the
cross-section value of porphyrin-based sensitizers, their chemi-
cal structure can be modified by: (i) the introduction of elec-
tron-donating (D) or electron-accepting (A) groups, (ii) the ex-
tension of their p-system, or (iii) the synthesis of symmetrical
(d-p-D, A-p-A) or asymmetrical (d-p-A) systems. Following this
strategy, compounds with very high TPA cross-sections could
be obtained (s2 6.1105 GM for Porphyrin-pyrene
in Scheme 27).[74] Other candidates for TPA-PDT in-
clude the amphiphilic RuII-porphyrin conjugates 59
and 60 with a hydrophilic cationic head (RuII com-
plex) and a hydrophobic tail (porphyrin) for en-
hanced cellular uptake (Scheme 27).[70] RuII and por-
phyrin cores were linked together via conjugated
spacers such as an acetylide[75a] or a Schiff base[75b] at
a b-pyrrolic position. TPA cross-sections of these RuII
conjugates and their 1O2 quantum yields (FD) were
significantly increased compared to those of H2TPP
(Scheme 27). These compounds were effective sensi-
tizers for PDT under mono-photonic excitation, but
were also effective under bi-photonic excitation at
lexc=850 and 800 nm for 59 and 60, respectively.
Therefore, up to 70% of HeLa cells were killed upon
laser excitation for 30 minutes (conditions of irradia-
tion for 59 : 5 mm, 4 hours incubation time, lexc=
850 nm; for 60 : 1 mm, 3 hours incubation time, lexc=
800 nm).
Other RuII porphyrin conjugates were reported in the litera-
ture where the RuII complex is connected to meso aryl[76] or
pyridyl[77] groups of the porphyrin. TPA cross-section values are
lower due to the perpendicular orientation of the meso aryl
group with respect to the porphyrin plane, preventing efficient
p-conjugation between the porphyrin and the RuII complex
(see RuII porphyrin conjugates 61–63 represented in
Scheme 28).[78] Interestingly, the nature of the spacers used to
link RuII complexes and porphyrins together have a strong in-
fluence on the subcellular localisation of the RuII-porphyrin
conjugates and hence, on the PDT efficiency.[78]
Scheme 27. Structures, two-photon absorption cross-sections s2 and
1O2 quantum yields
FD of H2TPP, Porphyrin-pyrene and Ru
II complexes 59 and 60 in CHCl3.
Scheme 28. Structures, two-photon absorption cross-sections s2 and
1O2 quantum yields
FD determined in CHCl3 of Ru
II-porphyrin conjugates 61–63.
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4.3. Porphyrins with peripheral gold complexes
Gold complexes are an interesting class of metallodrugs with a
great potential for cancer therapy with modes of action differ-
ent from those of platinum- or ruthenium-based drugs. Modes
of action of gold metallodrugs include mitochondrial damages,
inhibition of thioredoxine reductase, proteasome inhibition,
and modulation of specific kinase.[79] Although the potential of
AuIII porphyrin complexes (with AuIII in the macrocycle) as anti-
cancer agents is now quite well established (they are able to
induce apoptosis and cell cycle arrest),[80] the use of porphyrins
peripherally functionalized with gold complexes is in its infan-
cy and few examples are reported. Among these, neutral com-
plexes 64-M porphyrins with peripheral AuI-phosphine com-
plexes (Scheme 29)[81] proved to be non-toxic (IC50>200 mm)
towards HCT116 and SW480 colon cancer cells due to their
poor water solubility. The water-soluble complex 65 is more
toxic, with IC50 56 mm on HCT116 and 72 mm on SW480,
and the observed cytotoxicity is due to the peripheral AuI com-
plex. The water-soluble complex 65 was also an effective PS
for PDT because its cytotoxicity increased up to four times
upon illumination for 30 minutes with white light.
Although NHCs are best known as ligands for applications in
catalysis, the stability of the NHC-metal bond is an interesting
property for biomedical applications to prevent the premature
release of the metal ions and to improve the bioavailability of
the metallodrugs.[82] Free-base porphyrins fused to NHC-Aul-X
complexes 66–68 (X=Cl or thiolates, see Figure 7) were inves-
tigated for their photodynamic properties on MCF7 breast
cancer cells.[83] Compared to the corresponding imidazolium
salt 8-2H, the AuI porphyrin complex 66 is a better photosensi-
tizer, because the efficiency of 7-2H to generate 1O2 is about
60% that of AuI complex 66. This difference can be attributed
to the heavy atom effect exerted by the peripheral AuI com-
plex, as suggested by the lower fluorescence quantum yield
and lifetime of the imidazolium salt 8-2H compared to the AuI
porphyrin complex 66. The synthesis of thiolato-AuI com-
plexes 67 and 68 was achieved by substituting the chloride of
AuI complex 66 for thiolates. The AuI complex 68 is particularly
interesting for targeted PDT because it contains a mannose
group susceptible of targeting MCF7 breast cancer cells, which
are known to overexpress mannose receptors at their surface.
The mannose group also dramatically improves the solubility
of compound 68 in water. As illustrated in Figure 7 (right side),
all compounds presented limited cytotoxicity in the dark (less
than 20% cell death at a concentration of 10 mm). Upon irradi-
ation, imidazolium salt 7-2H induced 65% cell death due to
the strong interaction of cationic species like 8-2H with nega-
tively charged cell membranes. Whereas AuI complexes 66 and
67 showed limited phototoxicity, compound 68 functionalized
with mannose became very toxic upon irradiation and no
living MCF7 cells were detected. It was demonstrated that the
mannose group of 68 promoted active endocytosis in MCF7
cells via mannose receptors. The low photodynamic effects ob-
served with 66 and 67 may be explained by the absence of
specific targeting, thus limiting active endocytosis.
4.4. Porphyrins with peripheral gadolinium complexes
Theranostic agents allow simultaneous imaging and therapy
with a single molecular system. Therefore simple water soluble
porphyrins, such as H2TMPyP (Scheme 25), and most of the
peripherally metalated porphyrins presented in this section
can be considered as theranostic agents. They can be detected
by fluorescence imaging and, at the same time, used as a PS
for PDT. Adding different imaging modalities to theranostic
agents is of interest to accurately detect tumors. Magnetic res-
onance imaging (MRI) is a diagnostic technique offering sever-
al advantages, including an excellent spatial resolution without
using ionizing radiation. MRI relies on the use of contrast
agents (CAs) such as gadolinium(III) complexes·[84] The CA im-
proves the quality of the images by shortening the relaxation
rate of protons of H2O molecules that interact with Gd
III. The
longitudinal relaxivity r1 is directly related to the relaxation
rate: the higher the r1 value, the better the CA will be. In clini-
cal use, GdIII complexes with macrocycles like DOTA (H4DOTA=
1,4,7,10-tetraazacyclododecane-N,N’,N’’,N’’’-1,4,7,10-tetraacetic
acid) or chelating ligands like diethyleneaminepentaacetate are
extensively used, but have relatively low r1 values (3–
Scheme 29. Structure of AuI porphyrin conjugates 64-M and 65.
Figure 7. Left : structure of AuI porphyrin complexes 66–68 ; Right: Cytotoxic
(no laser) and photodynamic effect (laser) of imidazolium salt 7-2H and AuI
complexes 66–68. The cells were incubated or not (control experiment in
black) with 10 mm of PS for 4t and then submitted or not to laser irradiation
(l=405 nm, 18.75 Jcm2, 10 min). Cells were allowed to grow for 2 days
and cell viability was quantified with MTT assay. Data are mean values stan-
dard deviation from three independent experiments. *No living cells detect-
ed.
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6 mm1 s1 per GdIII) at clinical magnetic fields (1–3 T). Improv-
ing the r1 value with porphyrin macrocycles was first investi-
gated.[85] However, the inner cavity of porphyrins is too small
to accommodate GdIII adequately, and GdIII porphyrins are too
unstable for safe in vivo applications. The use of porphyrins
bearing peripheral and thermodynamically stable GdIII com-
plexes was a better option to combine within the same frame-
work PDT, fluorescence imaging and MRI. Moreover, synergistic
effects were expected. First, GdIII porphyrin conjugates should
present higher r1 values compared to commercially available
CAs because of their high molecular weights. Second, the hy-
drophilic peripheral GdIII complexes should improve the water
solubility. Finally, this hydrophilicity combined with the hydro-
phobic porphyrin confers an amphiphilic character to the con-
jugates and promotes endocytosis.
Among the GdIII porphyrin conjugates reported in the litera-
ture,[85–90] only those with four GdIII at the porphyrin periphery
(like those represented in Scheme 30) at 25 8C and 20 MHz are
discussed for better comparison. The tetranuclear GdIII com-
plex 69 is a free-base porphyrin bearing four meso DOTA-like
GdIII complexes.[87] The r1 value of 5.0 mm
1 s1 per GdIII is in
the range of commercially available GdIII based CAs. The tetra-
nuclear GdIII complex 70 contains diethylenetriamine-
N,N,N’’,N’’-tetraacetate (DTTA4) as peripheral chelating sites for
GdIII.[88] The higher r1 value of 14.1 mm
1 s1 per GdIII emphasiz-
es the advantage of using such peripheral [GdIIIDTTA] com-
plexes for better contrast. It is reasonable to assume that the
higher r1 value is due to the presence of two inner-sphere H2O
molecules per GdIII as for non-porphyrinic [GdIIIDTTA] com-
plexes[89] (only one H2O molecule per Gd
III in complex 69).
Complex 70 can also be used as a PS for PDT because it is able
to generate 1O2 upon irradiation with red light l=650
20 nm. For the free-base porphyrin 71 with four peripheral
[GdIIIDTTA] complexes (identical to those of complex 70) a
very high r1 value of 43.7 mm
1 s1 per GdIII was observed[90]
Comparing the chemical structures of complexes 70 and 71
highlights the advantage of using a shorter and more rigid
benzyl spacer instead of the longer and more flexible N-ethyl-
2-phenoxyacetamide. Complex 71 produces 1O2 in high yield
(FD=0.45 in H2O) and kills 50% of Hela cancer cells upon irra-
diation with red light (incubation with 6 mm of 71 for 24 hours,
l=635 nm, light dose=21 Jcm2). These compounds are all
promising theranostic agents for future biomedical applica-
tions.
5. Summary and Outlook
Continuous synthetic efforts to synthesize new chromophores
have led to innovative porphyrin derivatives containing periph-
eral coordination sites in addition to their classical inner cavity.
Numerous homo- and hetero-multimetallic species have been
reported during the last twenty years. Initially, many of these
beautiful structures were seen as laboratory curiosities without
clearly identified applications. However, combining the optic
and electronic properties of porphyrins with the electronic, cat-
alytic or biological properties of metal complexes can lead to
compounds with enhanced or new properties.
In the field of catalysis, the peripheral metal complex can
play the role of the catalytic site and the resulting catalytic ac-
tivity may be finely tuned by the porphyrin macrocycle. Axial
coordination to inner metal also offers an additional opportu-
nity to develop supramolecular catalysts or to perform dual
catalysis (both inner and outer metals are catalytic sites and
play complementary roles). Moreover, the porphyrin core can
be used as a light-harvesting unit for molecular photocatalytic
systems, thus avoiding the use of traditional Ru- or Ir-based
photoredox catalysts.
Porphyrins bearing peripheral coordination sites are suitable
building blocks for the synthesis of dimers or oligomers of por-
phyrins linked by metal ions. Depending of the peripheral li-
gands and the assembling metal ions, strong electronic com-
munication between the porphyrins was observed both in the
ground and in the excited states.
Beside catalysis, peripherally metalated porphyrins have bio-
medical applications because they offer a suitable combination
or properties for dual chemo- and photodynamic therapy. For
some compounds presented in this review, the overall ob-
served benefit is due to synergistic effects between the por-
phyrin and the peripheral metal complexes: the porphyrin im-
proves the cellular uptake of the metal complexes, while the
latter may improve the water solubility and/or the photody-
namic properties. Additional imaging modes such as MRI (GdIII)
may also be considered to develop new theranostics.
This summary highlighted the potential of peripherally
metalated porphyrins for catalysis, biomedicine and molecular
electronics. We presume that other applications, such as mo-
lecular sensors, will be considered in the future. One of the
next challenges is the synthesis of porphyrins with peripheral
non-noble metal complexes, since Pd, Pt and Ru have been
mainly used up until now. Such compounds might be interest-
ing for applications in (photo)catalysis or biomedicine.
Scheme 30. Structures of GdIII porphyrins 69–71 and corresponding relaxivi-
ties r1 (mm
1 s1) per GdIII measured at 25 8C and 20 MHz.
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